New study tests earlier treatment for low blood sugar in type 1 diabetes

NCT ID NCT04876079

Completed Knowledge-focused Sponsor: Institut de Recherches Cliniques de Montreal Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether giving oral glucose at a slightly higher blood sugar threshold can prevent mild-to-moderate hypoglycemia in people with type 1 diabetes. Thirty adults with type 1 diabetes were given 16g of oral carbohydrates when their blood glucose reached a target level. The goal was to see if this proactive approach reduces time spent with low blood sugar compared to current guidelines.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: oral glucose (16g carbohydrates)
What this could lead to: If successful, this could lead to simpler, more effective guidelines for preventing mild low blood sugar episodes in people with type 1 diabetes.
What could go wrong: This is a small, early study with only 30 participants. The results may not apply to everyone, and the approach might not work better than current guidelines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypoglycemia type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Montreal Clinical Research Institute

Montreal, Quebec, H2W 1R7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.